“It seems enormously valuable to me.” Perspectives of Dutch (potential) carriers of genetic FTD on onset-predictive biomarker testing

Abstract Background Onset-predictive biomarker tests (OPBT) in genetic frontotemporal dementia (FTD) may be used to recruit mutation carriers into preventive clinical trials before symptoms manifest. This would require disclosure of OPBT results to potential participants. This study investigates the...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Charlotte H. Graafland, Harro Seelaar, Jessica L. Panman, Lize C. Jiskoot, Tjitske Kleefstra, Jackie M. Poos, Edo Richard, Maartje H.N. Schermer, John C. van Swieten, Laura Donker Kaat, Eline M. Bunnik
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2025-05-01
סדרה:	Alzheimer’s Research & Therapy
נושאים:	Onset prediction Frontotemporal dementia Biomarker Ethics Genetic counselling Clinical trial recruitment
גישה מקוונת:	https://doi.org/10.1186/s13195-025-01749-z
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!